- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01763476
Atherectomy and Drug-Coated Balloon Angioplasty in Treatment of Long Infrapopliteal Lesions (ADCAT)
There is both a poor life expectancy and a poor prognosis of limb salvage in those patience with stenoses or occlusions of the lower limb (TASC Consensus). To date only a small number of these patients could be helped through medication or surgery. In fact within the first year following diagnosis of a critical limb ischemia 25% of patients lose their leg and 90% have to undergo a percutaneous transluminal angioplasty (PTA) or bypass surgery. Using PTA for treatment of long infrapopliteal artery lesions, stenosis reoccurs in 70% to 80% of cases 3 months after index procedure. Even the use of drug-eluting balloons leads only to 1-year primary patency rates up to 30%.
The primary objective of this study is to compare the performance of atherectomy followed by a drug-coated balloon angioplasty over drug-coated balloon angioplasty alone in long de-novo infrapopliteal lesions in a prospective, single-center, randomized clinical trial.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Bad Krozingen, Tyskland, 79189
- Universitäts-Herzzentrum Freiburg-Bad Krozingen
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Subject must be between 50 and 85 years old
- Female of childbearing potential must have a negative pregnancy test within 10 days prior to index procedure and utilize reliable birth control until completion of the 12-month angiographic evaluation
- Clinical diagnosis of symptomatic critical limb ischemia as defined by Rutherford 3, 4, or 5
- Single treatment of de-novo lesion(s) in the tibioperoneal trunk, anterior and/or posterior tibial and/or peroneal artery with a lesion length ≥6cm;
- One vessel in 1 limb may be treated in the study. Additional non-target lesion(s) in remaining non-target vessel(s) can be treated at the physician´s discretion by means of balloon dilation or stent placement
- The total length of target lesion(s) can be maximum 250 mm
- In total a maximum of 4 drug-coated balloons may be used to fully cover the target lesion
- Target vessel is 2.0 and 3.5 mm in diameter (visual estimate)
- Target lesion stenosis is >70% diameter stenosis (visual estimate)
- Guidewire must be across the target lesion and located intraluminally within the distal outflow vessel before study randomization
- Interventions in TASC A and B lesions to restore adequate blood flow, in the same index procedure are allowed. This intervention must be prior to the treatment of the study lesion(s) and successful
- Willing to comply with the specified follow-up evaluation
- Written informed consent prior to any study procedures.
Exclusion Criteria:
- Significant (>50%) stenoses distal to the target lesion (dorsalis pedis artery, plantar arch) that might require revascularization, or impede runoff;
- Angiographic evidence of thrombus within target vessel
- Thrombolysis within 72 hours prior to the index procedure
- In-Stent restenosis or restenosis of a native artery
- Aneurysm in the femoral artery or popliteal artery
- Concomitant hepatic insufficiency, thrombophlebitis, deep venous thrombus, coagulation disorder or receiving immunosuppressant therapy
- Recent myocardial infarction or stroke < 30 days prior to the index procedure
- Life expectancy less than 12 months
- Known or suspected active infection at the time of the index procedure, excluding an infection of a lower extremity wound of the target limb
- Known or suspected allergies or contraindications to aspirin, clopidogrel bisulfate (Plavix) and ticlopidine (Ticlid), heparin, or contrast agent
- Any significant medical condition which, in the investigator´s opinion, may interfere with the subject´s optimal participation in the study
- The subject is currently participating in another investigational drug or device study that has not completed the primary endpoint or that clinically interferes with the endpoints of this study.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Paclitaxel-coated balloon angioplasty
Target lesion to be treated with paclitaxel-coated balloon
|
plain balloon angioplasty followed by paclitaxel-coated balloon angioplasty of the target lesion
|
Aktiv komparator: Atherectomy + paclitaxel-balloon
Target lesion to be treated with atherectomy (TurboHawk, ev3) and paclitaxel-coated balloon
|
plain balloon angioplasty followed by paclitaxel-coated balloon angioplasty of the target lesion
atherectomy (TurboHawk, ev3) followed by paclitaxel-coated balloon angioplasty of the target lesion
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
primary patency
Tidsramme: 6 months
|
Primary patency of the target lesion 6 months after index procedure measured by duplex ultrasound (PVR>2.4)
and angiography (core lab analysis).
|
6 months
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
target lesion revascularisation (TLR)
Tidsramme: 6 and 12 months
|
Need for target lesion revascularisation from baseline to 6 months after index procedure.
|
6 and 12 months
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Change in Rutherford-Becker Class
Tidsramme: 6 and 12 months
|
Change in Rutherford-Becker Class from Baseline to 6 and 12 months after index procedure
|
6 and 12 months
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Studieleder: Franz-Josef Neumann, M.D., Universitaets-Herzzentrum Freiburg-Bad Krozingen
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Hjerte-kar-sygdomme
- Karsygdomme
- Åreforkalkning
- Arterielle okklusive sygdomme
- Åreforkalkning
- Perifere vaskulære sygdomme
- Perifer arteriel sygdom
- Molekylære mekanismer for farmakologisk virkning
- Antineoplastiske midler
- Tubulin modulatorer
- Antimitotiske midler
- Mitose modulatorer
- Antineoplastiske midler, fytogene
- Paclitaxel
Andre undersøgelses-id-numre
- ADCAT(2)
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Perifer arteriesygdom
-
Mayo ClinicTilmelding efter invitationAnatomi af GSV for Rescue Peripheral IV AccessForenede Stater
-
University Hospital OstravaRekrutteringIn-Stent Carotis Artery RestenosisTjekkiet
-
IRCCS Policlinico S. DonatoRekrutteringAnomalous aorta origin of the coronary artery (AAOCA)Italien
-
Sohag UniversityIkke rekrutterer endnuUmblical artery Doppler under terminsgraviditetEgypten
-
Inova Health Care ServicesBoston Scientific CorporationAfsluttetKoronar angiografi | Transradial adgang | Radial arterie Intimal Medial Tykkelse | Distal Radial Artery Access (dTRA)Forenede Stater
-
Baylor College of MedicineAfsluttetLungeblødning | MAPCA - Major Aortopulmonary Collateral ArteryForenede Stater
-
Daewoong Pharmaceutical Co. LTD.UkendtMCA - Middle Cerebral Artery DissektionKorea, Republikken
-
Resicardunion nationale de formation et d'evaluation en medecine cardio-vasculaireAfsluttetHjertefejl | Akut koronarsyndrom | Koronar bypass-graft Stenose af Native Artery GraftFrankrig
-
AldagenUkendtSlag | Iskæmisk slagtilfælde | Slagtilfælde i Middle Cerebral Artery (MCA)Forenede Stater
Kliniske forsøg med paclitaxel-coated balloon angioplasty
-
MedtronicRekrutteringFistel | Arteriovenøs fistel | Arteriovenøs fistelstenose | Arteriovenøs fistelokklusionForenede Stater
-
MedtronicAktiv, ikke rekrutterendeÅreforkalkning af femoral arterie | Obstruktiv sygdom | Aterosklerose af popliteal arterieFrankrig
-
Caritasklinik St. TheresiaUkendtPerifer arteriesygdom | Femoropoliteal stenose/okklusion | Skære-ballon | Drug-coated-ballonTyskland
-
Urotronic Inc.Aktiv, ikke rekrutterendeUrethral ForsnævringForenede Stater
-
C. R. BardAfsluttetFemoral arterieokklusion | Femoral arteriel stenoseBelgien, Østrig, Frankrig, Tyskland, Schweiz
-
Spectranetics CorporationAfsluttetPerifer arteriesygdomNew Zealand
-
Airiver Medical, Inc.RekrutteringKronisk rhinosinusitisParaguay
-
B. Braun Melsungen AGErnst von Bergmann HospitalAfsluttetKoronararteriesygdom (CAD)Tyskland
-
Boston Scientific CorporationAktiv, ikke rekrutterendeKoronararteriesygdomJapan